Recombinant Zebrafish CABP5A

• Cat.No.: CABP5A-10964Z
• Product Overview: Recombinant Zebrafish CABP5A full length or partial length protein was expressed.

Specification

• Source: Mammalian Cells
• Species: Zebrafish
• Tag: His
• Form: Liquid or lyophilized powder
• Endotoxin: < 1.0 eu per μg of the protein as determined by the LAL method.
• Purity: >80%
• Notes: This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
• Storage: Store it at +4 oC for short term. For long term storage, store it at -20 oC～-80 oC.
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: cabp5a calcium binding protein 5a [ Danio rerio (zebrafish) ]
• Official Symbol: CABP5A
• Gene ID: 393671
• mRNA Refseq: NM_200698
• Protein Refseq: NP_956992
• UniProt ID: F2Z4U8

Reviews

05/06/2022

Invaluable assistance for complex protein experiments.

09/26/2021

Crucial for our protein analysis and quantification.

12/13/2020

Streamlined purification methods, enhances our productivity.

Q&As

Are there specific proteins or molecules that are known to interact directly with CABP5A?

Interaction partners for CABP5A might be discerned using techniques like co-immunoprecipitation, yeast two-hybrid assays, or proteomics studies.

What is the primary biological function associated with CABP5A?

The specific function of CABP5A would need to be elucidated through functional assays and molecular studies.

Are there any documented genetic mutations in the CABP5A gene that influence its function or expression?

The impact of genetic mutations on CABP5A's function or expression can be explored through functional assays and genetic data analyses.

How does CABP5A contribute to cellular signaling or calcium modulation?

CABP5A's role in cellular signaling or calcium modulation would require pathway analysis, knockdown studies, or overexpression experiments.

Which post-translational modifications have been identified on CABP5A?

Post-translational modifications on CABP5A can be investigated using techniques like mass spectrometry or targeted biochemical assays.

Are there specific clinical conditions or diseases linked to CABP5A dysregulation?

Associations between CABP5A and specific diseases would require patient sample analyses, gene expression profiling, and a thorough review of the literature.

In which human tissues or cell types is CABP5A predominantly expressed?

Expression patterns of CABP5A can be determined using techniques such as qPCR, Western blotting, or immunohistochemistry.